Laxminarayan Bhat
2021
In 2021, Laxminarayan Bhat earned a total compensation of $600.1K as Chief Executive Officer and President at REVIVA PHARMACEUTICALS HOLDINGS, a 142% increase compared to previous year.
Compensation breakdown
| Bonus | $200,054 |
|---|---|
| Salary | $400,000 |
| Total | $600,054 |
Bhat received $400K in salary, accounting for 67% of the total pay in 2021.
Bhat also received $200.1K in bonus.
Rankings
In 2021, Laxminarayan Bhat's compensation ranked 10,317th out of 12,406 executives tracked by ExecPay. In other words, Bhat earned more than 16.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,317 out of 12,406 | 17th |
Division Manufacturing | 4,566 out of 5,492 | 17th |
Major group Chemicals And Allied Products | 2,043 out of 2,368 | 14th |
Industry group Drugs | 1,812 out of 2,089 | 13th |
Industry Pharmaceutical Preparations | 1,342 out of 1,536 | 13th |
Source: SEC filing on October 11, 2022.
Bhat's colleagues
We found two more compensation records of executives who worked with Laxminarayan Bhat at REVIVA PHARMACEUTICALS HOLDINGS in 2021.